Print this page

Meet Werfen at the 58th ERA -EDTA Congress!

ERA-EDTA, European Renal Association – European Dialysis and Transplant Association, is a major association of physicians having the goal of promoting the advancement of medical science fundamental and clinical advances in the field of nephrology, dialysis, renal transplantation, hypertension, and related subjects.

This Association is hosting their 58th ERA- EDTA Congress from June 5th to 8th both on-line and live in Berlin: Werfen will be there to deliver our contribution to the creation of new paths in the care of nephrology patients.

ERA-EDTA has gradually and successfully grown to respond to the challenges posed by scientific research on renal diseases, to the need to provide high-quality education on these diseases, and the importance of effective relationships with the institutions that fund scientific research in Europe.

During this event, Werfen will host an industry symposium on June 7th, aimed at discussing the clinical value that Glycated Albumin offers to manage patients suffering from diabetes or diabetic nephropathy.

Glycated Albumin is a mid-term glycaemic marker that reflects the average life of albumin. It is a unique marker capable to address and evaluate glycaemic status in DKD patients, highlighting therapy adherence and success or changes in glycaemic profiles and to reduce the risk of micro and macro vascular complications of diabetes mellitus.

This event is open to all nephrologists, diabetologists, laboratory doctors who have a real interest in knowing how to perform a finer, better and more effective glycaemic control on their patients, thus improving their outcome.

Spread the news and meet with us at our Industry Symposium: Werfen will be happy to welcome you in this innovative journey in glycaemic monitoring!

Visit our WebApp on Glycated Albumin for more information: GA.werfen.com

Clinical Chemistry Strategic Business Unit

Last modified on Tuesday, 31 May 2022 13:56